Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Follow-Up Questions
What is Abbott Laboratories (ABT)'s P/E Ratio?
The P/E ratio of Abbott Laboratories is 17.0617
Who is the CEO of Abbott Laboratories?
Mr. Robert Ford is the Chairman of the Board of Abbott Laboratories, joining the firm since 2014.
What is the price performance of ABT stock?
The current price of ABT is $125.87, it has increased 0.05% in the last trading day.
What are the primary business themes or industries for Abbott Laboratories?
Abbott Laboratories belongs to Health Care industry and the sector is Health Care
What is Abbott Laboratories market cap?
Abbott Laboratories's current market cap is $219.0B
Is Abbott Laboratories a buy, sell, or hold?
According to wall street analysts, 30 analysts have made analyst ratings for Abbott Laboratories, including 10 strong buy, 13 buy, 12 hold, 0 sell, and 10 strong sell
